tradingkey.logo

Cigna Group

CI
275.025USD
+1.275+0.47%
Fechamento 12/24, 13:00ETCotações atrasadas em 15 min
73.32BValor de mercado
12.08P/L TTM

Mais detalhes de Cigna Group Empresa

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Informações de Cigna Group

Código da empresaCI
Nome da EmpresaCigna Group
Data de listagemApr 01, 1982
CEOCordani (David M)
Número de funcionários73500
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 01
Endereço900 Cottage Grove Road
CidadeBLOOMFIELD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal06002
Telefone18602266000
Sitehttps://www.thecignagroup.com/
Código da empresaCI
Data de listagemApr 01, 1982
CEOCordani (David M)

Executivos da empresa Cigna Group

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+1.40%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+16.47%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+20.32%
Ms. Neesha Hathi
Ms. Neesha Hathi
Independent Director
Independent Director
3.37K
+23.36%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+1.40%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+11.66%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy revenues
53.65B
79.86%
Premiums
9.16B
13.63%
Fees and other revenues
4.14B
6.16%
Other revenues
236.00M
0.35%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy revenues
53.65B
79.86%
Premiums
9.16B
13.63%
Fees and other revenues
4.14B
6.16%
Other revenues
236.00M
0.35%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.73%
State Street Investment Management (US)
4.54%
T. Rowe Price Associates, Inc.
4.08%
MFS Investment Management
3.95%
Outro
73.11%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.73%
State Street Investment Management (US)
4.54%
T. Rowe Price Associates, Inc.
4.08%
MFS Investment Management
3.95%
Outro
73.11%
Tipos de investidores
Investidores
Proporção
Investment Advisor
52.73%
Investment Advisor/Hedge Fund
28.37%
Research Firm
2.55%
Pension Fund
2.25%
Bank and Trust
1.71%
Hedge Fund
1.58%
Sovereign Wealth Fund
1.39%
Corporation
1.19%
Individual Investor
0.39%
Outro
7.83%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
2907
242.25M
91.45%
+168.59K
2025Q3
2972
242.12M
91.90%
+1.54M
2025Q2
2981
240.55M
93.84%
-5.16M
2025Q1
2971
246.39M
94.63%
-8.92M
2024Q4
2988
249.03M
93.14%
+458.77K
2024Q3
2914
248.98M
92.53%
-1.29M
2024Q2
2894
250.44M
95.06%
-5.89M
2024Q1
2849
256.08M
92.56%
-14.53M
2023Q4
2795
262.30M
92.80%
-573.37K
2023Q3
2699
263.15M
93.94%
-4.31M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
25.60M
9.59%
-429.07K
-1.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
12.41M
4.65%
-851.92K
-6.42%
Jun 30, 2025
State Street Investment Management (US)
12.26M
4.59%
-209.47K
-1.68%
Jun 30, 2025
T. Rowe Price Associates, Inc.
9.90M
3.71%
-1.75M
-15.05%
Jun 30, 2025
MFS Investment Management
11.41M
4.28%
+104.02K
+0.92%
Jun 30, 2025
Dodge & Cox
8.95M
3.35%
+60.88K
+0.68%
Jun 30, 2025
Fidelity Management & Research Company LLC
8.81M
3.3%
-1.72M
-16.31%
Jun 30, 2025
Sanders Capital, LLC
7.79M
2.92%
-196.42K
-2.46%
Jun 30, 2025
GQG Partners, LLC
5.77M
2.16%
+883.02K
+18.07%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.96M
2.23%
-73.58K
-1.22%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares U.S. Healthcare Providers ETF
7.92%
VictoryShares Free Cash Flow ETF
3.31%
Invesco Dynamic Buyback Achievers ETF
3.22%
Monarch Dividend Plus Index ETF
2.79%
TrueShares Low Volatility Equity Income ETF
2.58%
Hennessy Sustainable ETF
2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
2.16%
Brandes US Value ETF
1.9%
Bushido Capital US Equity ETF
1.89%
Davis Select US Equity ETF
1.86%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção7.92%
VictoryShares Free Cash Flow ETF
Proporção3.31%
Invesco Dynamic Buyback Achievers ETF
Proporção3.22%
Monarch Dividend Plus Index ETF
Proporção2.79%
TrueShares Low Volatility Equity Income ETF
Proporção2.58%
Hennessy Sustainable ETF
Proporção2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
Proporção2.16%
Brandes US Value ETF
Proporção1.9%
Bushido Capital US Equity ETF
Proporção1.89%
Davis Select US Equity ETF
Proporção1.86%

Dividendo

Um total de 5.74B USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 22, 2025
CI.NB Final Cash Dividend of gross USD 1.51 paid on Dec 18, 2025 going ex on Dec 04, 2025 with reinvestment option
Dec 04, 2025
Dec 18, 2025
Dec 04, 2025
Jul 22, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Sep 18, 2025 going ex on Sep 04, 2025 with reinvestment option
Sep 04, 2025
Sep 18, 2025
Sep 04, 2025
Apr 23, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Jun 18, 2025 going ex on Jun 03, 2025 with reinvestment option
Jun 03, 2025
Jun 18, 2025
Jun 03, 2025
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024 with reinvestment option
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados

Perguntas frequentes

Quem são os cinco principais acionistas de Cigna Group?

Os cinco principais acionistas de Cigna Group são:
The Vanguard Group, Inc. detém 25.60M Ações, representando 9.59% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 12.41M Ações, representando 4.65% do total de Ações.
State Street Investment Management (US) detém 12.26M Ações, representando 4.59% do total de Ações.
T. Rowe Price Associates, Inc. detém 9.90M Ações, representando 3.71% do total de Ações.
MFS Investment Management detém 11.41M Ações, representando 4.28% do total de Ações.

Quais são os três principais tipos de acionistas de Cigna Group?

Os três principais tipos de acionistas da Cigna Group são:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

Quantas instituições possuem ações da Cigna Group (CI)?

Em 2025Q4, 2907 instituições possuíam ações da Cigna Group, com valor de mercado aproximado de 242.25M, representando 91.45% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em -0.45%.

Qual é a maior fonte de receita da Cigna Group?

Em FY2025Q2, o segmento de negócios Pharmacy revenues gerou a maior receita para Cigna Group, totalizando 53.65B e representando 79.86% da receita total.
KeyAI